This inventor holds 1 USPTO granted patent. Top assignee: Summit (Oxford) Limited. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Francis X Wilson: Innovator in Pharmaceutical Dosage Forms
Introduction
Francis X Wilson is a notable inventor based in Welwyn Garden, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of solid tablet dosage forms.
Latest Patents
Wilson holds a patent for a solid tablet oral dosage form of ridinilazole. This invention relates to the compound 2,2'-di(pyridin-4-yl)-1H,1′H-5,5′-bibenzo[d]imidazole, which is also known by various names including 2,2′-di-4-pyridinyl-6,6′-bi-1H-benzimidazole. The patent encompasses pharmaceutically acceptable derivatives, salts, hydrates, solvates, complexes, bioisosteres, metabolites, or prodrugs of ridinilazole.
Career Highlights
Francis X Wilson is associated with Summit (Oxford) Limited, where he has been instrumental in advancing pharmaceutical innovations. His work focuses on improving the efficacy and delivery of medications through innovative dosage forms.
Collaborations
Wilson has collaborated with notable colleagues such as Laura Trespidi and Jean-Francois Carniaux, contributing to a dynamic research environment that fosters innovation in drug development.
Conclusion
Francis X Wilson's contributions to the pharmaceutical industry, particularly through his patent on ridinilazole, highlight his role as an innovator in the field. His work continues to impact the development of effective medication delivery systems.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile